Saturday, July 11, 2026

pharma · Levodopa-Induced Dyskinesia

Xinhua Hospital, Shanghai

Xinhua Hospital, Shanghai is a pharma organization headquartered in CN. Primary therapeutic focus areas include Levodopa-Induced Dyskinesia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent rec

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Clinical program

Tianqi Pingchan Granule

Unknown · small molecule · Levodopa-Induced Dyskinesia

Tianqi Pingchan Granule for Levodopa-Induced Dyskinesia is a Unknown program (small_molecule) at Xinhua Hospital, Shanghai Jiao Tong University School of Medicine with 1 ClinicalTrials.gov record(s).

Internal code XHEC-C-2019-033-2

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Unknown
Modality
small_molecule
Indication
Levodopa-Induced Dyskinesia
Status
active
Trials
1